Chandrashekara S, Jaladhar Prakruthi, Paramshetti Shruti, Ramachandran Veena, Nizar Sayid Fahad, Kori Devaraj
Managing Director, ChanRe Rheumatology and Immunology Center and Research, Bengaluru, Karnataka.
Fellow in Rheumatology and Immunology, ChanRe Rheumatology and Immunology Center and Research, Bengaluru, Karnataka.
J Assoc Physicians India. 2020 Dec;68(12):33-34.
Incidence of viral pneumonia has been reported in several patients diagnosed with COVID-19. The infection has also been linked to the development of inflammatory syndromes and related clinical manifestations.
The present study discusses four cases of COVID infection showing varying clinical features. The post-COVID inflammation syndrome was associated with non-specific inflammation and post viral arthritis in three cases. One other subject had vasculitis leading to central retinal artery occlusion.
As the number of cases of COVID-19 cases has been increasing globally, it is advisable that physicians consider the possibility of post-COVID manifestations while examining patients with non-specific inflammation. A short course of NSAIDs and hydroxychloroquine regimen has been found to be beneficial for alleviating symptoms, and in rare cases with organ threatening inflammation, steroids may be required.
在数例确诊为 COVID-19 的患者中报告了病毒性肺炎的发病率。该感染还与炎症综合征的发展及相关临床表现有关。
本研究讨论了 4 例 COVID 感染病例,其临床特征各异。3 例 COVID 后炎症综合征与非特异性炎症和病毒后关节炎有关。另一名受试者患有血管炎,导致视网膜中央动脉阻塞。
由于全球 COVID-19 病例数一直在增加,建议医生在检查患有非特异性炎症的患者时考虑 COVID 后表现的可能性。已发现短期使用非甾体抗炎药和羟氯喹方案有助于缓解症状,在罕见的有器官威胁性炎症的情况下,可能需要使用类固醇。